Gossamer Bio Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.38

+0.01 (+1.61%)

As of Mar 24, 3:01 PM ET ·

Analyst Consensus

Buy

Analysts

High

Coverage

Buy 9 60%

Hold 5 33%

Sell 1 7%

Price Target

Analyst Price Target +7,128.4% upside

Low Target $18.46

Average Target $27.41

High Target $44.08

Current Price $0.38

Current
$0.38

Target
$27.41

$18.46 $27.41 avg $44.08

Scenario Analysis

Bear Case

$18.46

4,768.1%

Low target

Base Case

$27.41

+7,128.4%

Avg target

Bull Case

$44.08

+11,524.5%

High target

Risk/Reward

2.4x

Favorable

Price in Context

52-Week High

$3.87

-90.2% from high

52-Week Low

$0.33

+14.5% from low

Target vs 52W High

$27.41

+608.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+24.3%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-3.7%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-3.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-27.6%